ID: ALA591273

Max Phase: Preclinical

Molecular Formula: C11H10N2O2

Molecular Weight: 202.21

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)Nc1cnc(-c2ccccc2)o1

Standard InChI:  InChI=1S/C11H10N2O2/c1-8(14)13-10-7-12-11(15-10)9-5-3-2-4-6-9/h2-7H,1H3,(H,13,14)

Standard InChI Key:  NFIMCSVDAGIFPZ-UHFFFAOYSA-N

Associated Targets(Human)

Skin 286 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 202.21Molecular Weight (Monoisotopic): 202.0742AlogP: 2.30#Rotatable Bonds: 2
Polar Surface Area: 55.13Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.01CX Basic pKa: CX LogP: 1.27CX LogD: 1.18
Aromatic Rings: 2Heavy Atoms: 15QED Weighted: 0.81Np Likeness Score: -1.11

References

1. Lee PH, Conradi R, Shanmugasundaram V..  (2010)  Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay.,  20  (1): [PMID:19963379] [10.1016/j.bmcl.2009.11.039]

Source